Pharmacological agents that block monocytes TF activity, such as dilazep, may become a novel therapeutic approach in APS.
提示某些阻止单核细胞TF活性的药物可望成为治疗APS的新突破。
Pharmacological agents that block monocytes TF activity, such as dilazep, may become a novel therapeutic approach in APS.
提示某些阻止单核细胞TF活性的药物可望成为治疗APS的新突破。
应用推荐